from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3267/-

LFCtreatmentdescriptionclass of inhibitor

0.504

Amikacinug/mL Amikacintranslation

0.384

Cap5-10ug/mL Capreomycintranslation

1.295

Rox10-50 ug/mL Roxithromycintranslation

-0.338

SM2-5 ug/mL Streptomycintranslation

0.160

Tet5-10 ug/mL Tetracyclinetranslation

-0.056

Rif0.2-5ug/mL Rifampicintranscription

-0.138

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.498

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.144

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.085

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.886

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.666

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.641

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.341

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.174

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.551

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.450

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.025

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.429

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.167

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.442

KCN5-20 ug/mL Potassium cyaniderespiration

-0.210

NaN30.2-2 mM Sodium aziderespiration

-0.321

Nigericin50 uM Nigericinrespiration

-0.143

TRC10-150 ug/mL Triclosanrespiration

-0.237

TRZ10-25 ug/mL Thioridazinerespiration

-0.803

Valinomycin0.5-10 uM Valinomycinrespiration

-0.131

ZnSO42 mM ZnSO4respiration

-0.549

menadione6-10 ug/mL Menadionerespiration

-1.024

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.111

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.383

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.176

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-3.019

NRP_1Non-replicating persistence stage 1dosRassociated

0.466

Amp0.2mg/mL AmpicillincellWall

1.019

Cephalexin20-100 ug/mL CephalexincellWall

0.030

Cerulenin0.32-5 ug/mL CerulenincellWall

0.354

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.881

EMB10-20 ug/mL EthambutolcellWall

0.584

Eta12-40 ug/mL EthionamidecellWall

1.090

INH0.2-0.4 ug/mL IsoniazidcellWall

0.426

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.767

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.072

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.130

BZA0.12 mg/mL BenzamidearomaticAmides

0.559

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.409

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.374

H2O24 mM hydrogen peroxideDNAdamaging

0.145

Levo10 ug/mL LevofloxacinDNAdamaging

-0.122

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.405

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.051

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.048

UVUV-irradiationDNAdamaging

-2.064

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.713

Antimycin12.5-50 ug/mL Antimycin A?

-0.085

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.293

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.086

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.186

PA8240.2-2 ug/mL PA-824?

0.935

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.151

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.523

Verapamil50 uM Verapamil?

-0.516

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.586

methoxatin10-20 ug/mL Methoxatin?